Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Ching Hu

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Clinical and Experimental Neuropsychology|June 11, 2019
Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's diseaseKrista Specketer, Cyrus P Zabetian, Karen L Edwards, et al.
Parkinsonism & Related Disorders|August 16, 2017
Homocysteine and cognitive function in Parkinson's diseaseNicole Licking, Charles Murchison, Brenna Cholerton, et al.
Movement Disorders Clinical Practice|January 24, 2020
Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's DiseaseBrenna Cholerton, Kathleen L Poston, Lu Tian, et al.
Clinical Parkinsonism & Related Disorders|May 6, 2020
Prediction of cognitive progression in Parkinson's disease using three cognitive screening measuresHojoong M Kim, Carter Nazor, Cyrus P Zabetian, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 26, 2016
The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspotIgnacio F Mata, Marie Y Davis, Alexis N Lopez, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 13, 2016
The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspotIgnacio F Mata, Marie Y Davis, Alexis N Lopez, et al.
Pharmacoepidemiology and Drug Safety|December 21, 2013
Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health StudyThanh G N Ton, Mary Lou Biggs, Diane Comer, et al.
NPJ Parkinson'S Disease|September 5, 2020
Multivariate prediction of dementia in Parkinson's diseaseThanaphong Phongpreecha, Brenna Cholerton, Ignacio F Mata, et al.
Proteomics. Clinical Applications|March 21, 2017
An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionLi Yang, Tessandra Stewart, Min Shi, et al.
Molecular & Cellular Proteomics : MCP|January 4, 2015
Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validationMin Shi, James Movius, Romel Dator, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Clinical and Experimental Neuropsychology|June 11, 2019
Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's diseaseKrista Specketer, Cyrus P Zabetian, Karen L Edwards, et al.
Parkinsonism & Related Disorders|August 16, 2017
Homocysteine and cognitive function in Parkinson's diseaseNicole Licking, Charles Murchison, Brenna Cholerton, et al.
Movement Disorders Clinical Practice|January 24, 2020
Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's DiseaseBrenna Cholerton, Kathleen L Poston, Lu Tian, et al.
Clinical Parkinsonism & Related Disorders|May 6, 2020
Prediction of cognitive progression in Parkinson's disease using three cognitive screening measuresHojoong M Kim, Carter Nazor, Cyrus P Zabetian, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 26, 2016
The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspotIgnacio F Mata, Marie Y Davis, Alexis N Lopez, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 13, 2016
The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspotIgnacio F Mata, Marie Y Davis, Alexis N Lopez, et al.
Pharmacoepidemiology and Drug Safety|December 21, 2013
Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health StudyThanh G N Ton, Mary Lou Biggs, Diane Comer, et al.
NPJ Parkinson'S Disease|September 5, 2020
Multivariate prediction of dementia in Parkinson's diseaseThanaphong Phongpreecha, Brenna Cholerton, Ignacio F Mata, et al.
Proteomics. Clinical Applications|March 21, 2017
An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionLi Yang, Tessandra Stewart, Min Shi, et al.
Molecular & Cellular Proteomics : MCP|January 4, 2015
Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validationMin Shi, James Movius, Romel Dator, et al.
Pageof 6